Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Non-Hodgkin 1Lymphoma, AIDS-Related 1Lymphoma 1Hodgkin Disease 1HIV Infections 1Acquired Immunodeficiency Syndrome 1

Interventions

Etoposide 9Rituximab 8Cyclophosphamide 7Vincristine 6Prednisone 6Doxorubicin 5Filgrastim 4Cytarabine 3Radiotherapy 2Procarbazine 2Peripheral Blood Stem Cell Transplantation 2Melphalan 2Lomustine 2Carmustine 2prednylidene 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1liposomal doxorubicin 1ibrutinib 1ibritumomab tiuxetan 1etoposide phosphate 1efavirenz 1deltacortene 1VAP-cyclo protocol 1Ultrasonography 1Radioimmunotherapy 1Ondansetron 1O(6)-benzylguanine 1Mitoguazone 1Methylprednisolone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, AIDS-Related × Mitoguazone × Clear all
NCT00002348 2020-12-19

A Study of Mitoguazone Dihydrochloride in Patients With AIDS-Related Non-Hodgkin's Lymphoma

Sanofi

Phase 2 Completed
Lymphoid

Acquired Immunodeficiency Syndrome, Lymphoma, Non-Hodgkin, HIV Infections, Lymphoma, AIDS-Related

Data powered by HemOnc (CC BY 4.0) Colophon âš¡